Theravance (THRX) Price Target Lifted to $17 at BofA/Merrill Lynch
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Theravance (THRX) Declares $0.25 Quarterly Dividend; 5.7% Yield
February 23, 2015 4:11 PM ESTTheravance (NASDAQ: THRX) declared a quarterly dividend of $0.25 per share, or $1 annualized.
The dividend will be payable on March 31, 2015, to stockholders of record on March 12, 2015, with an ex-dividend date of March 10, 2015.
The annual yield on the dividend is 5.7 percent.
For a... More
Theravance (THRX) Tops Q4 EPS by 1c
February 18, 2015 4:19 PM ESTTheravance (NASDAQ: THRX) reported Q4 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $5.42 million.
For earnings history and earnings-related data on Theravance (THRX) click here.
... More